Shubhansh Bansal

Shubhansh Bansal

Auto-generated profile, based on publicly available information

Shubhansh Bansal

Centre of Research Impact and Outcome, Chitkara University, Rajpura, Punjab, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2024 in Seminars in Medical Writing and Education
Verified
Journal Article
Open access
PDF file
DSDharmsheel Shrivastava
Dharmsheel Shrivastava
MMMalathi. Malathi.H
Malathi. Malathi.H
SKSwarna Swetha Kolaventi
Swarna Swetha Kolaventi
BPBichitrananda Patra
Bichitrananda Patra
NRNyalam Ramu
Nyalam Ramu
SBShubhansh Bansal
Shubhansh Bansal
The rapid digitization of healthcare data has led to an exponential increase in unstructured clinical text, necessitating the integration of Natural Language Processing (NLP) in Medical Information Science. This research explores deep learning-based NLP techniques for clinical text analysis, focusing on Named Entity Recognition (NER), disease classification, adverse drug reaction detection, and clinical text summarization. The study leverages state-of-the-art transformer models such as BioBERT, ClinicalBERT, and GPT-4 Medical, which demonstrate superior performance in extracting key medical entities, classifying diseases, and summarizing electronic health records (EHRs). Experimental results on benchmark datasets such as MIMIC-III, i2b2, and ClinicalTrials.gov show that ClinicalBERT outperforms traditional ML models by achieving an F1-score of 89.9% in NER tasks, while GPT-4 Medical improves EHR summarization efficiency by 40%. By means of automated medical documentation, clinical decision support, and real-time adverse drug event detection which integrates NLP into healthcare systems diagnostic accuracy, physician efficiency, and patient safety are much improved. NLP-driven medical text analysis has great potential to transform clinical procedures and raise patient outcomes despite obstacles like computing costs, data privacy issues, and model interpretability. Improving domain-specific AI models, maximising real-time processing, and guaranteeing ethical AI deployment in healthcare should be the key priorities of next studies.

30 December 2024 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
SJSujayaraj Samuel Jayakumar
Sujayaraj Samuel Jayakumar
SSSourabh Kumar Singh
Sourabh Kumar Singh
VUVijay Jagdish Upadhye
Vijay Jagdish Upadhye
SPSouvagya Panigrahi
Souvagya Panigrahi
SBShubhansh Bansal
Shubhansh Bansal
MMMakarand B. Mane
Makarand B. Mane
Introduction: Environmental health, infectious disease control, environmental determinants of disease transmission, ecological exposures, COVID-19, air pollution, contagious diseases, and multisystem inflammatory syndrome in children (MIS-C)..Methods: The researcher used a mixed-methods approach, conducting both quantitative analyses of epidemiological data and qualitative interviews with public health experts. Multiple geographic locations with different environmental conditions were used to ascertain disease incidence. The study reviewed the existing literature to inventory and classify existing ecological health interventions..Results: The results showed a substantial association between better environmental health interventions and lower prevalence of communicable diseases. In regions with improved sanitation, access to clean water, and waste management, case studies confirmed a significant reduction in disease outbreaks. Interviews with experts emphasized that environmental health approaches can be integrated into existing public health efforts, such as those aimed at controlling vectors and reducing pollution..Conclusions: We show that enhanced environmental health systems were foundational to the control of infectious diseases [34]. Public health outcomes significantly improved through a recognition of ecological determinants and the application of targeted interventions. The study highlighted the need for policymakers to embrace environmental health in disease prevention approaches, suggesting more significant investment and intersect oral action to create sustained impacts.

20 August 2024 in Salud, Ciencia y Tecnología
Verified
Journal Article
Open access
PDF file
NRNithesh Babu Ramesh
Nithesh Babu Ramesh
PVPrasanna Venkatesh
Prasanna Venkatesh
TTTusha Tusha
Tusha Tusha
NANeha Nanditha Adepu
Neha Nanditha Adepu
ARAbinaya Srinivasa Rangan
Abinaya Srinivasa Rangan
SBShubhansh Bansal
Shubhansh Bansal
Background: Theeosinophilic infiltrate of the esophagus mucosal distinguishes the esophageal ailment known as Eosinophilicesophagitis (EoE). This study aims to determine the frequency of EoE in patients with gastroesophageal reflux disease (GERD), a gastro esophageal reflux condition that is persistent. Methods: The 248 children in total hadelectiveupper gastrointestinal endoscopy (UGIE) during the study period were separated in tosix groups: individuals without a history of steroid usage and those with outanesophageal biopsyforthrombocytopenia. As a result, 200 people participated in the study total. Results: After an evaluation of 200 children having elective UGIE, A variety of health problems were found during the investigation, including food bolusimpact (2 %), achalasia cardia (5 %), pepticstricture (6 %), congenitalstricture (3 %), post-esophageal atresia repairanastomoticstricture (4 %), and symptoms of gastro esophageal reflux, including vomiting (10 %), regurgitation (2 %), belchingchest (1,5 %), nocturnal cough (2,5 %), pain/heartburn (12,5 %), and feeding refusal (1 %). There were several unusual illnesses that were observed, including Crohn's disease accounted for 2 %, paediatric intestinal pseudo-obstruction (10 %), abdominal discomfort (17,5 %), celiacdisease (16 %), cow's milk protein allergy (3 %), and un classified IBD (7 %). Conclusion: EoEfrequently affects GERD patients who are recalcitrant to treatment. Dysphagia, food impaction, and heartburn are posible symptoms. EGD and esophageal biopsy should be explored for EoEscreening in elderly individuals with strong GERD who are atopy positive and who have not responded to gastric acid inhibitors.

16 August 2025 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
DPDevanshu J Patel
Devanshu J Patel
DSDivya Sharma
Divya Sharma
SBShubhansh Bansal
Shubhansh Bansal
DRDheeravath Raju
Dheeravath Raju
KCKabita Chanania
Kabita Chanania
MLManisha Laddad
Manisha Laddad
Trichomonas vaginalis, often known as T. vaginalis, is a protozoan that causes trichomoniasis, a prevalent sexually transmitted disease (STD) and a serious human pathogen. Glycogen is a branching polymer of glucose that the individual has been identified to accumulate for an elongated instance and then use when carbohydrates are insufficient. The crucial enzymes involved in glycogen production and investigate; Trichomonas vaginalis glycogen (TVG) syntheses and glycogen phosphorylase were considered. Research found that their regulatory features were different from known enzymes in animals and fungi. Bacterial recombinant synthesis of the open reading frames (ORF) TVAG 276310 produced proteins exhibiting branch and de-branch activity. Specifically, transgenic TVAG_276310 shows a preference for polysaccharides with long outside branches, which can include a substance and amylose undergrowth. Three proteins encompassed in the glucosidase formulation were identified by fluid chromatography and tandem mass spectrometry. The most notable was a putative-amylase, encoded by the TVAG_080000 ORF. Glycogen increase and branching were standardized after transgenic production of yeast cells devoid of enzyme movement that branches or de-branch glycogen.